AMLprofiler.

The AMLprofiler simplifies the challenging task to recognize Acute Myeloid Leukemia subtypes and make individualized therapy decisions.Read more

Companion Diagnostics.

Skyline is your partner of choice to develop signature-based tests to identify patient groups with favorable response profiles.Read more

MMprofiler.

Genomics offer powerful methods to identify unique genetic subtypes with specific clinical characteristics in MM.Read more

Skyline.

Skyline Diagnostics is a leader in the field of molecular medicine by developing and commercializing innovative, signature-based diagnostics.Read more

 
Bob Maarten Pieter Peter MMprofiler AMLprofiler
 
  • pharma

    Pharmaceutical companies

    Tailoring therapy based on genetic profiles of individual patients in order to maximize therapeutic response and to prevent adverse side-effects are essential to optimize modern health care. Skyline has all relevant expertise and know-how to discover genetic markers or signatures of clinical relevance and to develop these into practical and...

    Read more
     
  • arts

    Inventors of new biomarkers or signatures

    Skyline Diagnostics is a leading company in developing genetic biomarkers to reliable diagnostic assays of high clinical relevance.

    Read more
     
 

Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com